An interventional study of Subcutaneous peripheral nerve stimulation and SCS Only in Failed Back Surgery Syndrome, sponsored by Poitiers University Hospital. Completed at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-10-18.
Sponsored by Poitiers University Hospital · Not applicable, Interventional, and Treatment
Despite globally favourable outcomes of Spinal Cord Stimulation (SCS), a significant proportion of Failed Back Surgery Syndrome (FBSS) patients do not obtain adequate coverage of low back pain. Peripheral Nerve Stimulation (PNS) has obtained the European Conformity mark for the treatment of chronic refractory neuropathic pain and is now commonly used in some countries to target back pain. However, the potential value of combining SCS and PNS as "hybrid stimulation" remains poorly described with only isolated case reports or limited experience in various indications.
The "CUMPNS" comparative randomized study is designed to demonstrate the potential analgesic efficacy of PNS in addition to previously implanted SCS, to treat the residual low back pain component pain in refractory FBSS patients.
9,221 studies on the registry are indexed under Syndrome; 1,034 are open to participants now.
This study's enrollment of 14 is below the median of 50 across 6,517 interventional studies indexed under Syndrome.
Browse Syndrome studies →Poitiers University Hospital is the lead sponsor of 310 studies on the registry; 64 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Mutlticolumn SCS lead + Monocolumn SCS lead
Device: Subcutaneous peripheral nerve stimulation
Mutlticolumn SCS lead
Other: SCS Only
Relative change of low back pain surface (expressed as a percentage, %)
Time frame: 3 month follow-up
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Poitiers University Hospital